The Benefit of Chemotherapy in Esophageal Cancer Patients With Residual Disease After Trimodality Therapy
Kim, Grace J, Koshy, Matthew, Hanlon, Alexandra L, Horiba, M Naomi, Edelman, Martin J, Burrows, Whitney M, Battafarano, Richard J, Suntharalingam, Mohan
Published in American journal of clinical oncology (01.04.2016)
Published in American journal of clinical oncology (01.04.2016)
Get more information
Journal Article
Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of the Combination of Sorafenib and Tanespimycin
VAISHAMPAYAN, Ulka N, BURGER, Angelika M, SAUSVILLE, Edward A, HEILBRUN, Lance K, JING LI, HORIBA, M. Naomi, EGORIN, Merrill J, IVY, Percy, PACEY, Simon, LORUSSO, Patricia M
Published in Clinical cancer research (15.07.2010)
Published in Clinical cancer research (15.07.2010)
Get full text
Journal Article
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer
Casak, Sandra J, Horiba, M Naomi, Yuan, Mengdie, Cheng, Joyce, Lemery, Steven J, Shen, Yuan Li, Fu, Wentao, Moore, Jason N, Li, Yangbing, Bi, Youwei, Auth, Doris, Fesenko, Nataliya, Kluetz, Paul G, Pazdur, Richard, Fashoyin-Aje, Lola A
Published in Clinical cancer research (01.11.2023)
Published in Clinical cancer research (01.11.2023)
Get full text
Journal Article
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement
Patel, Timil H, Marcus, Leigh, Horiba, M Naomi, Donoghue, Martha, Chatterjee, Somak, Mishra-Kalyani, Pallavi S, Schuck, Robert N, Li, Yangbing, Zhang, Xinyuan, Fourie Zirkelbach, Jeanne, Charlab, Rosane, Liu, Jiang, Yang, Yuching, Lemery, Steven J, Pazdur, Richard, Theoret, Marc R, Fashoyin-Aje, Lola A
Published in Clinical cancer research (01.03.2023)
Published in Clinical cancer research (01.03.2023)
Get full text
Journal Article
FDA Approval Summary: Nivolumab for the Adjuvant Treatment of Adults with Completely Resected Esophageal/Gastroesophageal Junction Cancer and Residual Pathologic Disease
Horiba, M Naomi, Casak, Sandra J, Mishra-Kalyani, Pallavi S, Roy, Pourab, Beaver, Julia A, Pazdur, Richard, Kluetz, Paul G, Lemery, Steven J, Fashoyin-Aje, Lola A
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article
Geographical and baseline clinical characteristics of participants enrolled in hepatocellular carcinoma (HCC) trials: Analysis of US FDA approvals
Horiba, M. Naomi, Gandhy, Shruti U., Casak, Sandra J., Lemery, Steven, Kluetz, Paul, Pazdur, Richard, Fashoyin-Aje, Lola A.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article